In the gastrointestinal tract, interstitial cells of Cajal (ICCs) generate a pacemaker activity. They produce electric slow waves that trigger and coordinate gut smooth muscle contractions. Interstitial cells of Cajal's slender shape is revealed by KIT immunostaining. Based on several features, including KIT expression and KIT dependence, ICC-like cells were identified in nongastrointestinal tissues. Here, we investigated in the mouse whether uterine contractions depend on ICC-like cells' activity. By labeling KIT-expressing cells, we found putative ICC-like cells in the uterus, observed as KIT-positive interstitial, long spindle-shaped cells with fine branched cytoplasm processes, distributed in muscular layers and in subepithelial connective tissue. We then checked the potential KIT dependence of ex vivo contractile activity of the uterus by combining genetic and pharmacological approaches, using the Kit W-v hypomorphic mutation, and imatinib as a KIT noncompetitive inhibitor. We found a significant reduction in frequency of longitudinal uterine contractions in Kit W-v
INTRODUCTION
Digestive, urinary, and reproductive tracts are the main tubular organs in the abdominal cavity. Their contractile activity results from contraction of smooth muscle cells. In the gastrointestinal tract, interstitial cells of Cajal (ICC) are found between layers of muscular cells and act as pacemakers that initiate and coordinate slow wave electric activity and transmit action potential to smooth muscle cells, eventually leading to functional gastrointestinal motility [1, 2] . Interstitial cells of Cajal express KIT, a transmembrane receptor with tyrosine kinase activity. This distinctive feature allows labeling of ICC using immunohistochemical or molecular techniques and has made possible rapid progress in ICC research. KIT expression is required for ICC functional activities. In humans, alterations of ICC have been recorded in various digestive disorders, such as Hirschsprung disease, inflammatory bowel diseases, slow transit constipation, and other disorders of gastrointestinal motility, as well as in gastrointestinal stromal tumors [3] . Furthermore, in mice carrying loss-of-function mutations of the KIT signaling pathway, ICCs fail to develop in various regions of the gastrointestinal tract and spontaneous slow waves are lacking in the intestine, leading to uncoordinated peristalsis [4] . Finally, ICC function can be blocked by a KIT antibody or by a noncompetitive inhibitor of KIT tyrosine kinase activity, such as imatinib [5] [6] [7] . Imatinib is a 2-phenylaminopyrimidine derivative that binds to the same site as ATP, thus preventing phosphorylation of downstream substrates and inducing inhibition of KIT signaling. This molecular mechanism explains the beneficial use of imatinib in oncology in the treatment of chronic myeloid leukemia and of gastrointestinal stromal tumors, developed from KIT-positive ICCs [7] .
KIT expression and KIT dependence have been used as criteria to assess the existence of ICCs in tubular contractile organs other than the gastrointestinal tract. Recently, ICC-like cells have been described in the gallbladder [8] and in the urinary tract [9] [10] [11] .
The origin of the pacemaker activity responsible for myometrial contractions is still unknown. Specifically, the existence of KIT-positive ICC-like cells in the uterus is still debated in humans and in the rat [12] [13] [14] [15] and has not been investigated in the mouse. Detection of a pacemaker system in the reproductive tract would have important implications for our understanding of the physiology and pathophysiology of the female genital tract. It may provide new insights into a variety of frequent uterine conditions. In this report, we address the question of whether the murine uterus contains putative ICC-like cells, and if the activity of such cells is dependent on KIT expression. To this aim, we searched for and detected KIT-positive interstitial cells in the uterus of mice. Then, we investigated and compared the effect of KIT deficiency on the contractile activity of isolated murine uterus and on the control contractile activity of their duodenum. We recorded the ex vivo contractions of uterine horns coming either from Kit mutant mice or from wild-type mice, treated or not with imatinib. In both models, uterine longitudinal contractions were dramatically impaired. These concurrent results suggest that in mice, longitudinal contractions of the uterus depend on KIT signaling pathway activation in ICC-like cells.
MATERIALS AND METHODS

Animals
The 129S2/SvPa mice (referred to below as 129) carrying various alleles at the Kit locus were bred in our laboratory. The Kit alleles used were: Kit tm1Alf , Kit 
/Kit
W-v homozygotes are black-eyed, white-coated mice; they are sterile, suffer from a mild anemia, and display reduced intestinal contractions [5] .
Experiments were performed on mice 8 days after ovariectomy. This allowed us to abolish the variation in uterine contractile activity associated with the sex hormone status and to record higher spontaneous contractions as reported previously in the rat [18] 
W-v 129 females (3-5 mo old) were not ovariectomized, since they lack ovarian follicle development (Sakata et al. [19] and our own observations) and exhibit no estrous cycle.
Animals were fed ad libitum with standardized mouse pellet food (formula 1326; Génestil, Royaucourt, France). The ethics committee of Alfort School of Veterinary Medicine approved the provisions for animal care and use in accordance with European Union Standards.
Macroscopic and Microscopic Studies
Detection of lacZ expression in uterine horns and duodenum. The uterus of Kit tm1Alf /Kit þ 129 females was removed 8 days after ovariectomy, after section of the broad ligament of the uterus and of the vagina, then washed in PBS and fixed for 1 h at 48C in 4% paraformaldehyde (PFA) in PBS. The duodenum was also removed 2 to 3 cm distally from the pylorus part of the stomach to be used as a positive control.
For macroscopic studies, the uterus and duodenum were washed in PBS and soaked overnight at 328C in X-Gal solution (0.4 mg/ml 5-bromo-4-chloro-3-indolyl-D-galactoside, 2 mM potassium ferrocyanide, 2 mM potassium ferrocyanide, 11 mg/ml polyoxyethylene sorbitan monolaurate [Tween 20], and 4 mM MgCl 2 in PBS). Then, the organs were washed in PBS and postfixed overnight at 48C in 4% PFA. The uterus and duodenum were photographed with a Nikon Coolpix 995 camera.
For microscopic studies, the uterus and duodenum were embedded in paraffin and sectioned at 4 lm. Sections were stained with Giemsa and mounted in EuKitt. The samples were visualized with a Leica DMLB microscope (Rueil-Malmaison, France) and photographed with a CoolSnap, RS Photometric camera using RS Image 1.9.2 software (Ropper Scientific).
Detection of KIT expression in uterine horns and duodenum. The uterus and duodenum from Kit þ/þ females were removed 8 days after ovariectomy, the duodenum being used as a positive control. They were rinsed in PBS and fixed for 1 h at 48C in 4% PFA. After two successive washings in PBS, they were incubated overnight in 30% sucrose in PBS. They were embedded in O.C.T. (Tissue Tek), frozen in nitrogen vapors, and stored at À808C. Uterine horns and duodenum fragments were laid for longitudinal and transversal sections. Cryostat sections (10 lm) were placed on SuperFrost plus slides (Menzel Gläser), postfixed for 10 min in acetone, and stored at À808C. After thawing, the sections were placed for 10 min in acetone and rinsed three times for 5 min in PBS. Immunoflurescence detection of KIT was realized automatically with an immunostainer (Autostainer Plus; Dako). The sections were blocked for 20 min with 5% normal goat serum (Interchim) in PBS and incubated for 1 h at room emperature with a rat monoclonal antibody for mouse KIT (ACK2; Cliniscience), diluted at 1:50 in PBS with 5% normal goat serum. After three washings in PBS, the sections were incubated in darkness for 1 h at room temperature in a 1:200 goat anti-rat-IGH-3 (also called IgG2b) Alexa Fluor 488 antibody solution in PBS (Molecular Probes). After three washings in PBS, nuclear staining was performed by incubation for 3 min in a 1.25 lg/ml 4 0 ,6 0 -diamidino-2-phenylindole (DAPI) solution (Molecular Probes). A final rinse in PBS was followed by mounting (DAKO Fluorescent Mounting Medium). The sections were stored in darkness at 48C until use. Observations were made under a microscope (Apotome; Carl Zeiss) equipped with a fluorescent light digitized camera coupled to the Axiovision Image software (Axiovision rel. 4.6). [20] . Longitudinal measurements were taken in the middle of the horn diameter.
Measurements and analyses of contractile activity. Uterine horn and duodenal rings were placed in a double 20-ml organ bath in Krebs solution under a standard load of 0.2 3 g force (1.96 mN). Contractile activity was recorded with a force-displacement transducer (Biopac, Santa Barbara, CA), amplified with a DA100B amplifier (Biopac), and visualized using the Acknowledge-MP100 software (Biopac). The rings were allowed to equilibrate for 15 min. Contractions were recorded for at least 1 h and for 3 h maximum. Each genotype was tested at least on three uterine horns and three duodenal fragments. Frequency (number of contractions) and amplitude (mg) were analyzed for 30-min periods, recorded between 15 and 95 min after equilibration. The mean amplitude and frequency of contractions were compared between genotypes.
Pharmacological treatment of uterine rings. Imatinib mesylate (Glivec) was obtained from Novartis Pharma AG (Basel, Switzerland), dissolved in distilled water at 10 mM (stock concentration), and kept at À208C. Rings of uterine horns and duodenal fragments from Kit þ/þ 129 females were mounted as described above (bathed in a modified Krebs solution [pH 7.4] and gassed with 95% O 2 , 5% CO 2 ). After an equilibration time of 30 min in Krebs solution, imatinib was added to the bath. The effect of imatinib was evaluated at various concentrations on uterine horns at 8, 20, 40, and 80 lM, and at 20 and 80 lM for duodenal fragments. Each concentration was tested on at least three uterine horns and three duodenal fragments. We used a 35-mM KCl solution by replacing NaCl with equimolar KCl in Krebs solution. The horns incubated initially with 80 lM imatinib were exposed to a 35-mM KCl solution until an effective contractile response was observed.
Statistical analyses. Statistical analyses were performed with the StatView F-4.51.3 PPC software (Abacus Concepts, Berkeley, CA). Differences between groups in mean frequency and amplitude of contractions were statistically evaluated using a nonpaired Student t-test. A probability level of P , 0.05 was regarded as significant.
RESULTS
Detection of KIT-Expressing Cells in Murine Uterus
To investigate the existence of KIT-expressing cells, we searched for b-galactosidase-positive and KIT-positive cells in uterine horns and duodenum of Kit tm1Alf /Kit þ and Kit þ/þ 129 females, respectively, duodenal KIT-positive ICCs being used as positive control cells.
We first looked for the nuclear blue precipitate of bgalactosidase activity in uterus and duodenum from Kit tm1Alf / Kit þ 129 mice ( Fig. 1 ). In the duodenum, the staining appeared macroscopically diffuse and intense (Fig. 1A) ; labeled nuclei were elongated and were localized in the outer and inner muscular layers in histological sections (Fig. 1B) . They corresponded to the intestinal ICC nuclei. In the uterine horns, the staining was sparse compared with the dense duodenal labeling. It was present on the entire uterine circumference but was more concentrated on the mesometrial side (Fig. 1C) . On sections of the uterus, the nuclear staining identified a predominant population of cells with homogenous morphology. These cells were round to oval, with a round central nucleus and a moderately abundant perinuclear cytoplasm. Giemsa staining allowed identification of these cells as mast cells, with typical dense metachromatic purple granules in the cytoplasm (Fig. 1D) . Mast cells were seen mostly in the mesometrium and the serosa, between the muscular layers not far from small vessels, sometimes in smooth muscle bundles, and rarely in the endometrium.
UTERINE CONTRACTIONS DEPEND ON KIT ACTIVITY
To confirm KIT expression on the cell membrane, sections of uterus and duodenum from Kit þ/þ 129 females were labeled using an anti-KIT antibody (Fig. 2) . On duodenum sections, immunofluorescence revealed the intestinal ICCs in muscular layers: in the longitudinal outer layer, the ICC-MY of the myenteric plexus region, and in the circular inner layer, the ICC-DMP around the deep muscular plexus ( Fig. 2A) . On uterus sections, immunofluorescence revealed two distinct types of KIT-positive cells: 1) round mast cells, around 10 lm in diameter, detected under the serosa and around small vessels (Fig. 2, B and D, dashed arrows), and 2) long spindle-shaped cells with branched processes, sparsely distributed within the muscular layers and in the mucosa, in the subepithelial connective tissue layer (Fig. 2, B-F) . One type of ICC-like cells had elongated cell bodies with one or two primary processes and was preferentially located near the boundaries of uterine smooth muscle bundles (as shown in Fig. 2C ). The other type included multipolar cells, located among muscle bundles and in the subepithelial connective tissue layer (Fig. 2, E and F) .
Therefore, these two concurrent methods showed distinct types of KIT-positive cells in the myometrium: 1) round mast cells identified by their cytoplasm purple granules stained specifically by Giemsa, and 2) spindle-shaped cells with elongated thin branched processes, found in muscle layers and in mucosa of the uterus. The latter cells were morphologically very similar to intestinal ICCs; they were seen in the same locations, that is, either mixed with longitudinal and circular smooth muscle cells or in the connective tissue of the mucosa. Thus, KIT-positive interstitial cells were observed in the uterus of female mice and were referred to as putative ICC-like cells.
KIT Dependence of Uterine Contractile Activity
To investigate the role of Kit in spontaneous contractions of the uterus, we studied the effect of a reduction in the amount of KIT on contractile activity patterns of isolated uterine horns.
We first used a genetic approach. Figs. 3 and 4) . In a first step, we recorded circular contractile activity of uterine horns (Fig. 3) . 3) . Comparisons of the mean frequency and amplitude showed no significant difference between the three genotypes. Thus, a severe reduction in KIT concentration induces no effect on the frequency and amplitude of circular uterine contractions.
In a second step, we investigated the effect of the genotype at the Kit locus on the longitudinal contractile activity of isolated uterus horns (Fig. 4) 
/Kit
W-v females induces a reduction in the frequency of longitudinal contractions of uterus demonstrates that KIT is required to induce contractions in the uterus. Therefore, uterine longitudinal contractions are dependent on Kit function.
To confirm the involvement of Kit in myometrial contractions, we further used a pharmacological approach. The myometrium and duodenum contractile activities of adult Kit þ/þ 129 females were recorded ex vivo in the presence of 
UTERINE CONTRACTIONS DEPEND ON KIT ACTIVITY increasing concentrations of imatinib mesylate (Glivec).
Imatinib is a small molecule that behaves as a KIT noncompetitive inhibitor. It was previously reported that imatinib at different concentrations impairs circular contractile activity in ring preparations of the intestine, presumably as a result of KIT inhibition in ICCs [6] . To evaluate comparatively the effect of imatinib on uterine and duodenal contractile activities, longitudinal and circular activities were recorded (Figs. 5-7) . Imatinib was added to the bath at 20 and 80 lM for the duodenum and at 8, 20, 40, and 80 lM for the uterus. Each imatinib concentration was tested on at least three organ fragments. Compared with untreated controls, the frequency and amplitude of circular duodenal contractions were decreased in the presence of imatinib, with a dose-response relationship (Fig. 5, A-D) . The same effects of imatinib were also recorded on longitudinal muscular contractions of the duodenum (Fig. 5 , E-H). Compared with untreated controls, imatinib induced no disruption of frequency or amplitude of uterine circular contractions (Fig. 6) . By contrast, the frequency and amplitude of longitudinal myometrial contractions were impaired in the presence of imatinib, with a dose-response relationship (Fig. 7) . At the lowest concentration, namely 8 lM, imatinib severely reduced the frequency of the contractions without reducing their amplitude. The frequency was further decreased at 20 and 40 lM. Furthermore, at these concentrations, imatinib induced a reduction in the amplitude of uterine contractions. At 80 lM, imatinib led to a complete abolishment of the longitudinal contractions. After treatment with 80 lM imatinib, a muscular contraction was recorded by washing out imatinib with a fresh buffer containing 35 mM KCl, which showed that the smooth muscles were intact and were still able to contract (Fig. 7E) . Thus, imatinib, a specific inhibitor of KIT tyrosine kinase signaling, induced a dose-dependent reduction in the frequency of uterus longitudinal contractions. In the presence of increasing amounts of imatinib, the amplitude of myometrial contractions was also impaired.
Therefore, both genetic and pharmacological approaches lead to the same conclusion. Contractions of longitudinal uterine smooth muscles are dependent upon KIT activity. KIT acts upon the frequency and amplitude of longitudinal contractions of the uterus.
DISCUSSION
Both ICCs in the digestive tract and ICC-like cells in other tubular contractile organs, such as the biliary and urinary tracts, are considered as pacemakers for spontaneous activity of smooth muscles [2, 10, 11] . A well-accepted hallmark of these cells is their expression of the KIT receptor that displays tyrosine kinase activity. KIT expression is essential for ICC development and function in the intestine. Mutant mice with Kit loss-of-function are deficient in ICCs, lack spontaneous slow waves in the intestine, and have uncoordinated peristalsis [4] [5] [6] 21] . Furthermore, alterations of ICCs have been reported in numerous gastrointestinal diseases [3] .
The existence of ICC-like cells in the mouse uterus had not been investigated to date. We took advantage of the mouse model to search for the existence and function of putative ICClike cells in the uterus, using two criteria: KIT expression and KIT dependence. Indeed, both features participate in the definition of ICCs in the digestive tract and of ICC-like cells in other tubular contractile organs, such as the biliary and urinary tracts. Duodenal ICCs and duodenal contractile activity were studied as controls.
KIT-Positive Cells in the Uterus: Mast Cells and Putative ICC-Like Cells
Concurrent results were obtained using the Kit tm1Alf reporter gene and immunofluorescence with an anti-KIT antibody. Both models revealed two morphological types of KIT-expressing cells in the uterus. The first cell type was made of mast cells. They were seen under the serosa, around small vessels in the interstitial tissue, and also inside smooth muscle bundles. The second cell type was observed around smooth muscle bundles as interstitial long spindle-shaped cells with fine branched tortuous cytoplasm processes distributed among, between, and around the smooth muscle bundles and in the connective tissue of the endometrium. The finding that uterine interstitial cells express KIT, that they are located in intimate contact with smooth muscle cells and exhibit a slender morphology with long processes strongly suggests that these cells are ICC-like cells. Furthermore, these ICC-like cells share the same location and the same morphology as ICC-like cells described in the upper urinary tract and urethra [10, 11] , in the human fallopian tube [15] and in the guinea pig gallbladder [8] .
We observed an intimate cellular contact between KITpositive, ICC-like cells and mast cells. This close contact could have a functional role: an increase in smooth muscle contractility of the uterus can be obtained by a mast celldependent pathway via their degranulation [22] . Therefore, not 514 only ICC and ICC-like cells, but also mast cells, may play a role in pacemaking or in the transmission of spontaneous excitation.
In previously published reports, KIT expression in uterine ICC-like cells remained controversial. Indeed, ICC-like cells were found to be KIT positive in human uterus (see review in Popescu et al. [15] ), but KIT negative and vimentin positive in rat and human uterus [14] . These apparently contradictory results could suggest the coexistence in the uterus of at least two subpopulations of ICC-like cells that are different in terms of KIT expression. Indeed, it is becoming clear that in various tissues, ICC and ICC-like cells can be divided in subpopulations on the basis of their immunoreactivity or immunonegativity for KIT and other markers [10] . Nevertheless, the location and morphology of the KIT-positive, ICC-like cells we describe in the mouse uterus are very similar to the KITnegative, ICC-like cells described previously in rat and human uterus [14] . These data allow us to suggest a great variability in KIT sensitivity among organs of various species.
Our results support the presence of KIT-positive, ICC-like cells in the uterus of mice. Ultrastructural and functional electrophysiological studies would be required to compare ultrastructural morphology of uterine ICC-like cells to that of typical gut ICC and to check their identity as electric slow wave-generating cells. Together, our study reveals KIT- 
KIT Dependence of Uterine Longitudinal Contractile Activity
Spontaneous contractions were recorded from uterine horns of adult ovariectomized females as regular sinusoidal patterns from inner circular and outer longitudinal muscular layers. This implies that an automatic and coordinated contractile activity exists in the uterus, as it is known in the intestine (Fig. 5) , and that this activity can be elicited ex vivo, independently of either neural inputs or hormonal signals.
Interestingly, our experiments showed both a dramatic reduction in contraction frequency in the uterus of 
/Kit
W-v mice, a residual activity of KIT is still present, allowing recording of uterine contractions, even if their frequency is greatly reduced. By contrast, with high concentrations of imatinib, the KIT pathway is entirely blocked, and uterine contractions are abolished.
The finding that genetic and pharmacological approaches are in complete agreement suggests that loss of a functional KIT signaling abolishes longitudinal contractile activity of the myometrium. These data reveal that KIT is part of the functional pathway that induces spontaneous longitudinal contractions in the uterus of mouse.
The reinduction of the longitudinal contractions using a KCl solution on uterine horns initially blocked by imatinib showed that smooth muscle cells had not lost their ability to contract and were unaffected in the presence of imatinib. This finding demonstrates that imatinib acts upstream of the excitation-contraction coupling in smooth muscle cells. This suggests that Imatinib, acting as a KIT noncompetitive inhibitor, blocks the signal transmitted to the smooth muscle cells; this signal is emitted by another cell population, presumably the ICC-like cells. This result, together with the identification of ICC-like cells in the uterus, strongly suggests that ICC-like cells do play a KIT-dependent central role in the generation and coordination of the myometrial contractile activity, similarly to what is known to happen for gastrointestinal motility.
The KIT dependence of longitudinal uterine contractions is quite similar to the KIT dependence of intestinal contractions. Previous results have demonstrated that KIT is necessary for circular contractile activity of the mouse small intestine [6] . Our results confirm these data and show that both longitudinal and circular contractions of the intestine are dependent on KIT. Importantly, identical concentrations of imatinib induced inhibition of contractions in the intestine and in the uterus, suggesting that imatinib may act on the same molecular pathway in both organs. The fact that in the uterus only the longitudinal contractile activity depends on KIT, whereas in the intestine both the circular and longitudinal activities depend on KIT, may reflect organ or ICC specificities.
In the absence of a functionally KIT transduction pathway, it can be surprising to observe the blockage of the longitudinal uterine contractions while the circular uterine contractions are apparently unaffected. This result would imply that the two subpopulations of ICC-like cells are not equivalent. This point is already documented for the ICCs in the small intestine. The ICC-MYs of the small intestine are pacemaker cells that generate electrical slow waves [4, 6] . In Kit W /Kit W-v mice, ICC-MY number is severely reduced and slow waves are lost in spite of a normal distribution of ICC-DMPs [2, 21] . By contrast, ICC-DMPs, involved in the mediation or modulation of enteric neurotransmission, are not affected in Kit W /Kit W-v animals. These data suggest different functions shared between the various classes of ICCs in the gut mouse. Different functions could also be shared between the various classes of ICC-like cells in the uterus. Imatinib is a noncompetitive inhibitor binding to the same site as ATP. It blocks selectively the tyrosine kinase activity of KIT but also of other tyrosine kinase receptors, such as ABL and platelet-derived growth factor receptor, alpha and beta polypetides (PDGFRA and PDGFRB) [23] . PDGFRB is expressed in human [24] and mouse myometrium [25] , and could therefore be another target of imatinib in the uterine horns. Although we cannot rule out an additional involvement of the PDGFR pathway in the generation of myometrial contractile activity, our experiments with the uterus of Kit W-v
W-v females demonstrate that Kit plays a major role in the contractile activity of the uterus.
Medical Perspectives
The hypothesis that uterine ICC-like cells require KIT to induce myometrial contractions suggests that ICC-like cells may be a relevant target for new therapeutic strategies in a variety of uterine diseases. It might be of interest to test imatinib on hypercontractility of the uterus in cases of 516 menstrual pain [26] and in fertility management to enhance chances of embryonic implantation [27] .
Gastrointestinal stromal tumors are distinguished from leiomyosarcomas based on their KIT expression, and their treatment with tyrosine kinases inhibitors, such as imatinib, has proven its efficiency [7, 23] . Sarcomas of the uterus account for a small percentage of uterine cancers. However, they are associated with a high recurrence rate and a poor overall survival rate [28] . Interestingly, KIT expression was found in leiomyosarcomas of the uterus [29] . Imatinib is already being tested in clinical trials in this indication [28] .
The existence of KIT-positive, ICC-like cells in the myometrium contributes to our understanding of contractile activity of the uterus and may lead to new approaches in the treatment of uterine contractility disorders and tumoral proliferations of these cells.
